As shown in Figure 4C, oxazolone-induced IL-6 and TNF-α levels were greatly decreased in the CA-treated wild-type AD mice, whereas CA failed to reduce the level of these cytokines in RCAN1 knockout AD mice. This evidence concerns the gene RCAN1 and Alzheimer disease.